Gowling WLG’s Cannabis team advised Celadon Pharmaceuticals PLC on strategic collaboration with Valeos. Celadon Pharmaceuticals PLC (“Celadon”), a UK-based company specializing in cannabis-based medicines, has entered...
You must be a Standard 1 Year member to access this content.
Gowling WLG advised Eloxx Pharmaceuticals on a licence agreement. Eloxx Pharmaceuticals, a company engaged in the science of ribosome modulation, has recently entered into an exclusive...
You must be a Standard 1 Year member to access this content.
Gowling WLG advised Sosei Heptares on a multi-million pound drug with Boehringer Ingleheim. Sosei Heptares, a leading biopharmaceutical company, has joined forces with Boehringer Ingelheim in...
You must be a Standard 1 Year member to access this content.
Withers tech team has advised biotech research firm Kynos Therapeutics on the deal. Kynos Therapeutics’ £9 million financing consisted of £6.5 million led by Epidarex Capital together with...
You must be a Standard 1 Year member to access this content.
